Product NDC: | 68462-334 |
Proprietary Name: | Pramipexole dihydrochloride |
Non Proprietary Name: | Pramipexole dihydrochloride |
Active Ingredient(s): | 1.5 mg/1 & nbsp; Pramipexole dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68462-334 |
Labeler Name: | Glenmark Generics Inc., USA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090781 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101008 |
Package NDC: | 68462-334-05 |
Package Description: | 500 TABLET in 1 BOTTLE (68462-334-05) |
NDC Code | 68462-334-05 |
Proprietary Name | Pramipexole dihydrochloride |
Package Description | 500 TABLET in 1 BOTTLE (68462-334-05) |
Product NDC | 68462-334 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pramipexole dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20101008 |
Marketing Category Name | ANDA |
Labeler Name | Glenmark Generics Inc., USA |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | 1.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |